AB-BIOTICS

A new clinical study from AB-BIOTICS and Kaneka Probiotics demonstrates that Gyntima Menopause can significantly improve menopausal symptoms and quality of life, offering a science-backed, natural approach to supporting women through the menopause transit

A New Clinical Trial in Moderately Stressed, Healthy Overweight Adults The new clinical study developed by AB-Biotics and Kaneka Probiotics highlights the potential of Lactiplantibacillus plantarum KABP 051 as a next-generation solution targeting both bod

Discovering the Latest Trends in Biotics With so many of our partners already in Barcelona for Vitafoods Europe 2026, we saw the perfect opportunity to bring them together. On Tuesday, May 5th, we hosted the first edition of our Global Probiotics Networki

Can a heat-treated probiotic strain improve your skin from the inside out? New clinical evidence suggests yes. A newly published clinical study has found that the postbiotic strain Latilactobacillus sakei KABP-065, developed by AB-BIOTICS, can help suppor

Upper respiratory infections (URIs) are a frequent challenge for young children, often causing several days of fever, discomfort and disrupted family routines. A newly published clinical study in European Journal of Pediatrics now shows that AB21, a propr

Maintaining a healthy vaginal microbiota is essential to women's overall well-being. Yet, stress, antibiotics, and hormonal changes can disrupt this delicate ecosystem-known as vaginal dysbiosis-increasing the risk of infections like bacterial vaginosis (

A newly published randomized controlled trial has confirmed the efficacy of INNERIM, AB-BIOTICS' probiotic blend designed for adults aged 50+, in improving both constipation and stress. Published in the Journal of Dietary Supplements, the study evaluated

We're pleased to share that our scientifically validated probiotic formulations have been officially included in the 2025 edition of the AEProbio Clinical Guide to Probiotic Products - UK Edition. This independently reviewed clinical reference helps healt

The first quarter of 2025 has marked an important period for AB-BIOTICS, with three major launches across key global markets. These rollouts reflect our ongoing commitment to science-backed innovation and strategic partnerships in areas with high unmet ne